Disparities in Pediatric Provider Availability by Insurance Type After the ACA in California

Jessie Kemmick Pintor1, Héctor E Alcalá2, Dylan H Roby3

  • 1Department of Health Management and Policy (JK Pintor, CK Alberto, RM McKenna, and AN Ortega), Dornsife School of Public Health, Drexel University, Philadelphia, Penn.

Academic Pediatrics
|September 16, 2018
PubMed

Insights

Children with Medi-Cal or private insurance faced greater provider barriers than those with employer-sponsored plans. These insurance-based disparities highlight access challenges in California's healthcare market.

Area of Science:

  • Health Services Research
  • Health Policy
  • Pediatric Health

Background:

  • The Affordable Care Act (ACA) reshaped the health insurance market.
  • Understanding insurance-based disparities in healthcare access is crucial for vulnerable populations.

Purpose of the Study:

  • To investigate provider-related barriers to care experienced by children in California.
  • To examine how these barriers differ based on insurance type post-ACA.

Main Methods:

  • Analysis of 6514 children (0-11 years) from the 2014-2016 California Health Interview Survey.
  • Examined parent-reported difficulties in finding providers, provider acceptance, and insurance acceptance.
  • Used multivariable models to assess associations between insurance type (Medi-Cal, employer-sponsored, private) and reported barriers.

Main Results:

  • Approximately 8% of parents reported at least one provider barrier.
  • Children with Medi-Cal (Medicaid) or privately purchased coverage had double the odds of experiencing barriers compared to those with employer-sponsored insurance.
  • Medi-Cal enrollees faced higher odds of difficulty finding providers and being accepted as new patients. Privately insured children had higher odds of facing insurance acceptance issues.

Conclusions:

  • Significant insurance-based disparities in provider-related barriers exist for children in California.
  • Findings underscore the need for policies to mitigate these access barriers and ensure equitable care.
  • The study highlights ongoing challenges in provider networks and acceptance across different insurance plans.
Abstract

Related Concept Videos

The Availability Heuristic01:08

The Availability Heuristic

A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):
7.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
233
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
301
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
72.9K